PRNews

Arab Health 2025|Yuwell Medical Announces Strategic Investment and Partnership with Inogen in Respiratory Health

Cision | Mon, Jan 27 2025 02:25 PM AEDT

1695367561_650d4189d32c8_1692951951_64e8658fe70f4_breaking_news_600.png
Image Source: Sivastatz

DUBAI, UAE, Jan. 27, 2025 /PRNewswire/ -- On the eve of the Arab Health Exhibition, Yuwell Medical held its 2025 Global Core Partner Conference in Dubai, and announced a strategic investment and partnership with Inogen, a leading U.S. company in respiratory health, highlighting our joint commitment to advancing medical device solutions and deeper collaboration.

Alex WU, Chairman of Yuwell Medical, giving the speech
Alex WU, Chairman of Yuwell Medical, giving the speech

Speaking at the Yuwell Medical 2025 Global Core Partner Conference, Alex WU, Chairman of Yuwell Medical, stated that as a leading enterprise in China's home medical device industry, Yuwell will rely on internal growth and external mergers and acquisitions to promote internationalisation. The company has updated its new vision for the next five years: to become top three companies in the global home medical health market in the mid-to-long term. Among them, respiratory treatment solutions, diabetes care, and emergency service solutions are the three key strategic sectors. The company will further strengthen its globalization strategy from three aspects: organizational structure expansion, recruitment of outstanding overseas talents product R&D innovation, and supply chain integration innovation.

He further emphasized, "In the process of realizing the new vision, Yuwell will work hand in hand with global partners to provide users with more competitive products and better health solutions."

During the conference, Yuwell Medical and the American company Inogen formalized their collaboration by signing a strategic investment and cooperation memorandum, further deepening their partnership in the respiratory segment.

Yuwell Medial and Inogen formalized a strategic investment and cooperation
Yuwell Medial and Inogen formalized a strategic investment and cooperation

As one of the world's largest manufacturers of oxygen concentrators, Yuwell Medical is widely recognized for its strong R&D capabilities and advanced manufacturing capabilities.

Inogen, a leading U.S. manufacturer of oxygen concentrators, brings extensive experience in portable oxygen concentrator technology. Yuwell, through its whole-owned subsidiary Yuwell (Hong Kong) Holdings Limited, has agreed to invest approximately $27.2 million in Inogen, representing 9.9% of the outstanding shares of Inogen's common stock upon closing of this investment.

The two companies seek to upgrade devices technology through deepened collaboration. By combining their expertise and brand in their respective industry segments and geographies, Yuwell and Inogen agree to carry out in-depth strategic cooperation based on business synergy in four aspects: international distribution business, trademark licensing and distribution business, joint research and development, and supply chain optimization.

Yuwell Medical and Inogen are excited to build a long-term strategic partnership, ready to take advantage of emerging opportunities in today's market. Together, they aim to enhance their international competitiveness and deliver innovative products that improve lives worldwide.

Looking forward, Yuwell Medical will stay focused on innovation, driving breakthroughs in medical technology, and working with global partners to shape the future of healthcare.

World News

The Joy of Missing Out: How People Connect Through Loud Budgeting

We all want to start off the new year with shiny new things — like, perhaps, a new device! But does ...

3BL | Tue, Jan 28 2025 03:15 AM AEDT

Read More
World News

Comcast Premieres ‘Our Blues Make Us Gold,’ a Compelling Documentary Celebrating North Carolina A&T’s Global Impact and Historic Legacy

Key TakeawaysDocumentary showcases the nation’s largest Black university’s unique position as both a powerhouse in STEM education and ...

3BL | Tue, Jan 28 2025 03:00 AM AEDT

Read More
PRNews

ThinkCyte expands product portfolio to drive innovation in drug discovery and disease research.

TOKYO, Jan. 28, 2025 /PRNewswire/ -- ThinkCyte, a biotechnology company pioneering novel artificial intelligence (AI)-based cell analysis and sorting instruments, announced ...

Cision | Tue, Jan 28 2025 03:00 AM AEDT

Read More
Stock Market

Walmart+ membership continues to reach new heights, Morgan Stanley says

Investing.com -- Walmart+ membership has seen a significant rebound, with current figures suggesting approximately 26.5 million members, or about 17.2 million ...

Investing | Tue, Jan 28 2025 02:53 AM AEDT

Read More
PRNews

bbSOL Unveils its Largest Airdrop on Bybit Web3

DUBAI, UAE, Jan. 27, 2025 /PRNewswire/ -- Bybit, the world's second-largest crypto exchange by trading volume, is unleashing the rewarding power of ...

Cision | Tue, Jan 28 2025 02:43 AM AEDT

Read More